russ2000_2_0664|VRCA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0664|VRCA|1|Verrica Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Verrica Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Verrica Pharmaceuticals Inc Inventories (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Verrica Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Verrica Pharmaceuticals Inc Book Value (Quarterly) (USD)|Verrica Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Verrica Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc EV to Revenues|Verrica Pharmaceuticals Inc EV to Earnings|Verrica Pharmaceuticals Inc EV to Free Cash Flow|Verrica Pharmaceuticals Inc EV to Assets (Quarterly)|Verrica Pharmaceuticals Inc PS Ratio|Verrica Pharmaceuticals Inc PE Ratio|Verrica Pharmaceuticals Inc Price to Book Value|Verrica Pharmaceuticals Inc PEG Ratio|Verrica Pharmaceuticals Inc Debt to Equity Ratio|Verrica Pharmaceuticals Inc Dividend Yield|Verrica Pharmaceuticals Inc Shareholder Yield (TTM)|Verrica Pharmaceuticals Inc Percent of Shares Outstanding Short|Verrica Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Return on Invested Capital|Verrica Pharmaceuticals Inc Quality Ratio Score|Verrica Pharmaceuticals Inc Momentum Score|Verrica Pharmaceuticals Inc Beta (1Y)|Verrica Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Verrica Pharmaceuticals Inc Institutional Investor Ownership Percentage|Verrica Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Verrica Pharmaceuticals Inc Total Employees (Annual)|Verrica Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Verrica Pharmaceuticals Inc Shares Outstanding|Verrica Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Verrica Pharmaceuticals Inc Payout Ratio|Verrica Pharmaceuticals Inc Quick Ratio (Quarterly)|Verrica Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Verrica Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Verrica Pharmaceuticals Inc Effective Tax Rate (TTM)|Verrica Pharmaceuticals Inc Return on Equity|Verrica Pharmaceuticals Inc Net Income (TTM) (USD)|Verrica Pharmaceuticals Inc Revenue (TTM) (USD)|Verrica Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Verrica Pharmaceuticals Inc Revenue (Quarterly) (USD)|Verrica Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Verrica Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Verrica Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Price (USD)|Verrica Pharmaceuticals Inc Total Return Price (USD)|Verrica Pharmaceuticals Inc Enterprise Value (USD)|Verrica Pharmaceuticals Inc 30-Day Average Daily Volume|Verrica Pharmaceuticals Inc 1 Year Price Returns (Daily)||
russ2000_2_0664|VRCA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0664|VRCA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
russ2000_2_0664|VRCA|5|91.2|91.2||91.2||91.2|91.2|91.2||91.2|91.2|91.2|||1.44949494949||||1.44949494949|||1.44949494949||15.2363636364||91.2|91.2|||30.5|30.5333333333||30.5|91.3076923077|182.5|91.3076923077|38.0952380952||91.2|||91.3076923077|91.4|||91.2|||||91.3076923077|91.3076923077|91.3076923077|91.3076923077|1.44949494949|1.44949494949|1.44949494949|1.44955752212|1.44023323615||
russ2000_2_0664|VRCA|6|10|10||10||10|10|10||10|10|10|||594||||594|||594||55||10|10|||14|15||14|13|4|13|21||10|||13|10|||10|||||13|13|13|13|594|594|594|565|343||
russ2000_2_0664|VRCA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
russ2000_2_0664|VRCA|201703||||||||||||||||||||||||||||||||||19.9464||-0.0286||||||-0.0286|||||||||0.055|-0.57|-0.57||||||||
russ2000_2_0664|VRCA|201706||||||||||||||||||||||||||||||||||19.9464||-0.0549||||||-0.0549|||||||||0.118|-1.095|-1.095||||||||
russ2000_2_0664|VRCA|201709||||||||||||||||||||||||||||||||||19.9464||-0.0681||||||-0.0681|||||||||0.238|-1.359|-1.359|-0.001|||||||
russ2000_2_0664|VRCA|201712|9.083|8.663||||16.124|0.616|15.508||-7.041|-12.435|||||||||||||||0.167||||||||19.9464|11|-0.3377|||24.9464|||-0.0719||||-4.459|||||0.316|-1.435|-1.435|-0.001|||||||
russ2000_2_0664|VRCA|201803|28.905|27.485||0.019||1.648|1.648|||27.748|-14.309|||||||||||||||0.618|0.002|||||||24.9464||-0.074|24.9464||24.9464|||-0.074||||-5.736|||||0.961|-1.847|-1.847|0.041|||||||
russ2000_2_0664|VRCA|201806|104.59|103.149||0.112||3.125|3.125|||101.591|-20.268||||-74.6158||||17.7379|||||0.1227||1.117|0.003|||||||5.7513|11|-0.92|25.6964||25.6964|||-0.92|-86.25|||-9.958|||||1.955|-5.317|-5.317|0.153|19.73|19.73|464.7075|30375.0333||17.4|17.6
russ2000_2_0664|VRCA|201809|98.677|96.975||0.114||2.451|2.451|||96.354|-27.007||||-35.9088||||4.1103|||||0.6617||1.105|0.003|||||||24.8475|15|-0.24|25.6964||25.6964|||-0.24|7.876|||-14.505|||||2.865|-5.906|-5.906|0.427|16.25|16.25|314.4175|100175.4667||13.2|12
russ2000_2_0664|VRCA|201812|91.152|89.809||0.255||2.477|2.477|||89.429|-33.083||||-6.4181||||2.3426|||||0.5482||0.96|0.003|||||||25.7048|16|-0.3|25.7048||25.7048|||-0.3|-7.876|||-20.648|||||3.271|-7.578|-7.578|0.61|8.15|8.15|119.6851|42005.3||11.97|11.32
russ2000_2_0664|VRCA|201903|84.677|83.282||1.288||3.218|3.062|0.156||82.761|-40.464||||-10.0862||||3.1074|||||2.389|0.006|1.136|0.003|||||||24.8578||-0.3|25.7085||25.7085|||-0.3||||-26.28|||||3.539|-7.479|-7.479|0.547|10.81|10.81|188.0869|75228.5||10|7.13
russ2000_2_0664|VRCA|201906|79.739|78.754||1.497||4.405|4.281|0.124||76.845|-47.465||||-9.2097||||3.6096|||||2.8177||1.473|0.003|||3|3.9747||56.9744|24.8756||-0.28|25.7403||25.7403|||-0.28||||-27.964|||||3.593|-7.001|-7.001|0.523|11.62|11.62|215.4508|57742.5333|-40.7143|12.24|9.91
russ2000_2_0664|VRCA|201909|74.04|71.078||2||4.421|4.33|0.091||71.653|-53.555||||-11.2632||||5.3032|||||2.221||1.01|0.003|||3|4.5136||58.6749|24.893||-0.24|25.7448||25.7448|||-0.24||||-28.148|||||3.494|-6.09|-6.09|0.453|14.76|14.76|308.9152|62127.7333|-9.1692|13.52|15.07
russ2000_2_0664|VRCA|201912|64.983|62.017||2.201||3.409|3.351|0.058||65.015|-61.192||||-12.379||||6.3023|||||2.2234||1.185|0.003|||9|5.6428||74.2917|24.9648|17|-0.31|25.7863||25.7863|||-0.31||||-28.207|||||4.018|-7.637|-7.637|0.354|15.89|15.89|347.7273|90379.9667|94.9693|14.51|11.87
russ2000_2_0664|VRCA|202003|90.647|88.382||2.42||37.834|3.302|34.532||56.608|-71.014||||-7.6635||||4.9843|||||3.0879||1.103|0.003|||7|2.8626||71.7619|24.9642||-0.39|25.8145||25.8145|||-0.39||||-30.55|||||4.988|-9.822|-9.822|0.058|10.93|10.93|228.2045|75183.1333|1.1101|12.07|11.48
russ2000_2_0664|VRCA|202006|83.338|79.622||2.517||38.773|38.698|0.075||48.463|-80.423||||-7.157||||5.8646|||||3.2167||1.297|0.003|||9|1.1649||59.9166|24.9656||-0.38|25.8145||25.8145|||-0.38||||-32.958|||||5.11|-9.409|-9.409|-0.778|11.01|11.01|239.3156|74364.5333|-5.2496|6.56|9.19
russ2000_2_0664|VRCA|202009|||||||||||||||-4.6325||||4.1228|||||9.8796||||||4|1.1071||58.4381||||||||||||||||||||||7.74|7.74|154.9022|236509.4667|-47.561|8.47|